Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications - Soultati, Aspasia; Mountzios, Giannis; Avgerinou, Chrysoula; Papaxoinis, George; Pectasides, Dimitrios; Dimopoulos, Meletios-Athanassios; Papadimitriou, Christos (Cancer treatment reviews, 2012)
Keywords: Angiogenesis Inhibitors - adverse effects; Angiogenesis Inhibitors - pharmacology; Angiogenesis Inhibitors - therapeutic use; Anthracyclines - adverse effects; Antimetabolites; Antimetabolites - adverse effects; Antimetabolites - pharmacology; Antineoplastic Agents - adverse effects; Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Bleomycin - adverse effects; Cyclophosphamide - adverse effects; Cytotoxics; Endothelium; Endothelium, Vascular - drug effects; Flow-mediated dilatation; Hematology, Oncology and Palliative Medicine; Humans; Methotrexate - adverse effects; Nitrate-mediated dilatation; Platinum compounds; Platinum Compounds - adverse effects; Platinum Compounds - pharmacology; Taxanes; Taxoids - pharmacology; Taxoids - therapeutic use; Toxicity; Vascular endothelial growth factor; Vinca alkaloids; Vinca Alkaloids - pharmacology; Platinum compounds; Toxicity; Nitrate-mediated dilatation; Flow-mediated dilatation; Vinca alkaloids; Taxanes; Vascular endothelial growth factor; Antimetabolites; Cytotoxics; Endothelium